EUVIMEDEUVIMED entdecken
Crossref

Deoxycalyxin A exerts hypoglycemic effects through activating TGR5-induced GLP-1 secretion via TGR5/PKA/MEK/ERK pathway

Sheng-Li Wu, Xiao-Feng He, Pianchou Gongpan, Xiao-Yan Huang, Chang-An Geng

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.110516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Sheng-Li Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China; Univer…. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Receptors, G-Protein-Coupled, Glucagon-Like Peptide 1, Diabetes Mellitus, Type 2. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Chinese Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is a heterogeneous metabolic disorder characterized by insulin resistance and progressive β cell dysfunction. Deoxycalyxin A (DCA), a unique diarylheptanoid-chalcone hybrid isolated from Alpinia katsumadai, was identified as a novel stimulator of GLP 1 secretion in both STC-1 (EC50: 10.7 μM) and NCI-H716 (EC50: 13.4 μM) cells. Oral administration of DCA (40 and 80 mg/kg) in db/db mice significantly reduced fasting blood glucose, ameliorated glucose intolerance and insulin resistance by enhancing endogenous GLP-1 secretion, and lowered the total serum cholesterol levels. Mechanistic study demonstrated that DCA identify the TGR5 receptor, which induces a significant increase in intracellular cyclic AMP (cAMP) levels, which activates PKA with subsequent sequential phosphorylation of MEK1/2 and ERK activation, ultimately enhancing GLP-1 secretion. Our findings identify DCA as a novel TGR5 agonist to stimulate GLP-1 secretion via the TGR5/PKA/MEK/ERK pathway, which has the potential to be developed as a promising antidiabetic lead with a distinct mechanism of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsReceptors, G-Protein-CoupledGlucagon-Like Peptide 1Diabetes Mellitus, Type 2AnimalsMiceCyclic AMP-Dependent Protein KinasesHumansStructure-Activity RelationshipMAP Kinase Signaling SystemDose-Response Relationship, DrugMolecular StructureMaleMice, Inbred C57BLAlpinia

Stichwörter der Autor:innen

Deoxycalyxin A (DCA)GLP-1 secretionHypoglycemic effectPKA/MEK/ERK pathwayTGR5 agonistType 2 diabetes mellitus

Substanzen

Hypoglycemic AgentsReceptors, G-Protein-CoupledCyclic AMP-Dependent Protein KinasesGlucagon-Like Peptide 1Gpbar1 protein, mouseGPBAR1 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China; University of Chinese Academy of Sciences, Beijing 100049, China.
  • State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China.
  • State Key Laboratory of Phytochemistry and Natural Medicines, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming 650201, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic…

Förderung

  • National Key Research and Development Program of China
  • Chinese Academy of Sciences

Zitieren

APA

Wu, S. L., He, X. F., Gongpan, P., Huang, X. Y., & Geng, C. A. (2026). Deoxycalyxin A exerts hypoglycemic effects through activating TGR5-induced GLP-1 secretion via TGR5/PKA/MEK/ERK pathway. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110516

Vancouver

Wu SL, He XF, Gongpan P, Huang XY, Geng CA. Deoxycalyxin A exerts hypoglycemic effects through activating TGR5-induced GLP-1 secretion via TGR5/PKA/MEK/ERK pathway. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110516

BibTeX
@article{Wu2026,
  author = {Wu, Sheng-Li and He, Xiao-Feng and Gongpan, Pianchou and Huang, Xiao-Yan and Geng, Chang-An},
  title = {Deoxycalyxin A exerts hypoglycemic effects through activating TGR5-induced GLP-1 secretion via TGR5/PKA/MEK/ERK pathway},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.110516}
}
Kostenlos starten →